Why United Therapeutics (UTHR) Shares Are Falling Today

What Happened? Shares of biotechnology company United Therapeutics NASDAQ:UTHRfell 4% in the afternoon session after Goldman Sachs initiated coverage of the stock with a Sell rating.Goldman Sachs analyst Andrea Newkirk began covering the biotechnology company with the negative rating. A Sell rating…